One of the companies that could come into sharp focus among investors today is Ludwig Enterprises Inc (OTCMKTS:LUDG), after it stock soared by as much as 17% yesterday after the company sent out a letter addressed to its shareholders.
On Wednesday, LUDG stock jumped 17.39% to $0.2700 with more than 25.35K shares, compared to volume of 21.23K shares. The stock moved within a range of $0.2650 – 0.2900 after opening trade at $0.2900.
Ludwig Enterprises Releases Annual 2022 Shareholder Letter
The company is one of the best known innovators and invented the inflammatory biomarkers meant for diagnosing chronic conditions. It may be a good move from investors to take a look at some of the highlights from the letter in order to make sense of the rally. The company announced that it had made considerable progress over the course of the past four to six months and that included the acquisition of mRNA genomic technology. The technology could facilitate in revolutionizing the healthcare industry.
The company also announced that it had filed a patent for its Precision Genomics MRNA Inflammatory Index and also launched MyRNAfor Life Inc, a subsidiary unit. The subsidiary in question is meant for marketing antioxidant nutraceutical formulation from Ludwig which helps in modulating inflammatory substances which are released by the immune cells.
In addition to that, the company had also managed to sign up for the SRAX Shareholder Platform and that had proven to be one of its key milestones for 2022 as well.